Financial reports
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
15 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-K/A
2021 FY
Annual report (amended)
12 May 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
28 Mar 22
Current reports
8-K
Completion of Acquisition or Disposition of Assets
3 Apr 24
8-K
Entry into a Material Definitive Agreement
1 Mar 24
8-K
Entry into a Material Definitive Agreement
16 Feb 24
8-K
Regulation FD Disclosure
16 Jan 24
8-K
Departure of Directors or Certain Officers
22 Nov 23
8-K
Other Events
15 Nov 23
8-K
Kinnate Biopharma Inc. Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
9 Nov 23
8-K
Kinnate Biopharma Inc. Announces Pipeline Updates, Strategic Reprioritization and Workforce Restructuring
18 Sep 23
8-K
Kinnate Biopharma Inc. Reports Second Quarter 2023 Financial Results and Recent Corporate Updates
8 Aug 23
8-K
Amendments to Articles of Incorporation or Bylaws
28 Jul 23
Registration and prospectus
15-12G
Securities registration termination
17 Apr 24
S-8 POS
Registration of securities for employees (post-effective amendment)
3 Apr 24
S-8 POS
Registration of securities for employees (post-effective amendment)
3 Apr 24
S-8 POS
Registration of securities for employees (post-effective amendment)
3 Apr 24
POSASR
Automatic shelf registration (post-effective amendment)
3 Apr 24
SC 14D9/A
Tender offer solicitation (amended)
3 Apr 24
25-NSE
Exchange delisting
3 Apr 24
SC TO-T/A
Third party tender offer statement (amended)
3 Apr 24
SC 14D9/A
Tender offer solicitation (amended)
22 Mar 24
SC 14D9/A
Tender offer solicitation (amended)
19 Mar 24
Other
EFFECT
Notice of effectiveness
27 Apr 22
EFFECT
Notice of effectiveness
3 Dec 20
CORRESP
Correspondence with SEC
2 Dec 20
UPLOAD
Letter from SEC
2 Dec 20
CERT
Certification of approval for exchange listing
1 Dec 20
CORRESP
Correspondence with SEC
30 Nov 20
CORRESP
Correspondence with SEC
30 Nov 20
CORRESP
Correspondence with SEC
30 Nov 20
UPLOAD
Letter from SEC
23 Nov 20
CORRESP
Correspondence with SEC
16 Nov 20